<DOC>
	<DOC>NCT00802451</DOC>
	<brief_summary>The purpose of this study is to evaluate the relative bioavailability of the test formulation of mesalamine suspension rectal enema with the reference formulation in healthy, adult subjects.</brief_summary>
	<brief_title>Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations</brief_title>
	<detailed_description />
	<mesh_term>Mesalamine</mesh_term>
	<criteria>healthy men or women, 18 to 55 years of age weight within +/ 25% for height and weight for body frame willing to participate and sign a copy of the informed consent form recent history of drug or alcohol addiction or abuse pregnant or lactating women history of allergic response to mesalamine evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant receipt of any drugs as part of a research study within 28 days prior to study dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Mesalamine</keyword>
</DOC>